Last reviewed · How we verify

High hyal Plus inj.

Huons Co., Ltd. · Phase 3 active Small molecule

High hyal Plus is a hyaluronic acid-based injectable that provides viscoelastic supplementation and tissue hydration for joint or dermatological applications.

High hyal Plus is a hyaluronic acid-based injectable that provides viscoelastic supplementation and tissue hydration for joint or dermatological applications. Used for Osteoarthritis (likely knee or other joints), Dermatological applications (skin hydration/rejuvenation).

At a glance

Generic nameHigh hyal Plus inj.
SponsorHuons Co., Ltd.
Drug classHyaluronic acid derivative
TargetHyaluronic acid receptors (CD44, RHAMM)
ModalitySmall molecule
Therapeutic areaOrthopedics / Dermatology
PhasePhase 3

Mechanism of action

Hyaluronic acid is a naturally occurring polysaccharide that acts as a lubricant and shock absorber in joints and connective tissues. The 'Plus' formulation likely indicates an enhanced or cross-linked version designed to improve retention time and efficacy. This mechanism supports tissue hydration, reduces friction, and may promote healing in damaged or degenerative tissues.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: